PHA Classroom banner

>>Back to All Recordings

>>Back to Living with PH Recordings
>>Back to 2012 Conference Session Recordings

Session Recording from PHA's 2012 10th International PH Conference
Obesity, Diet Treatments and PH

June 23, 2012

Diet pills have been implicated as a cause of PAH. However, obesity may also play a role in the development of the disease. Maintaining an ideal body weight can improve symptoms of PAH. This session will address the role of diet pills, obesity as a cause of PAH and the importance of a healthy lifestyle and maintaining an ideal weight.

Presenter Information

Namita Sood, MD, FCCP, Ohio State University Medical Center, Columbus, Ohio (Chair); Loida Johnson, CRNP, University of Maryland Medical Center, Baltimore, Md.; Tim Lahm, MD, Indiana University School of Medicine, Indianapolis, Ind.








Actelion Pharmaceuticals US, Inc. Gilead Sciences, Inc. United Therapeutics Corporation Bayer HealthCare
This is a program of the PHA Medical Education Fund, made possible through unrestricted educational grants from our supporters.


FacebookGoogle +TwitterLinkedInPinterestInstagramYouTubeBloggerFeedsPHAware Download our App

The information provided on the PHA website is provided for general information only. It is not intended as legal, medical or other professional advice, and should not be relied upon as a substitute for consultations with qualified professionals who are familiar with your individual needs.

801 Roeder Road, Ste. 1000, Silver Spring, MD 20910   Patient-to-Patient Support Line: 1-800-748-7274
    Privacy Policy    Provide Feedback & Report Bugs

Designed by Matrix Group International, Inc.® | © 2015 Pulmonary Hypertension Association. All Rights Reserved.


The National Organization for Rare Disorders (NORD) awarded PHA the Abbey S. Meyers Leadership Award in 2012 for outstanding service to PHA members in advocacy, education and other key areas.